Surasa Nagachinta - Search Results

Year	Number of Results
2020	2
2022	1
2024	1
2025	2
2026	3

1

Preclinical synergistic effects when combining a radiolabelled HER2-targeting single domain antibody with PARP inhibitor Olaparib.

Dewulf J, Navarro L, Dumauthioz N, Berdal M, Nagachinta S, Gaspariunaite V, Pombo Antunes AR, Lahoutte T, Massa S, Devoogdt N, D'Huyvetter M. Dewulf J, et al. Among authors: nagachinta s. J Transl Med. 2025 Dec 13;24(1):83. doi: 10.1186/s12967-025-07572-2. J Transl Med. 2025. PMID: 41390415 Free PMC article.

2

Fully automated ¹⁸F-fluorination of N-succinimidyl-4-[¹⁸F]fluorobenzoate ([¹⁸F]SFB) for indirect labelling of nanobodies.

Nagachinta S, Novelli P, Joyard Y, Maindron N, Riss P, Dammicco S. Nagachinta S, et al. Sci Rep. 2022 Nov 4;12(1):18655. doi: 10.1038/s41598-022-23552-8. Sci Rep. 2022. PMID: 36333403 Free PMC article.

3

Head-to-head comparison of FAP-targeting single-domain antibody 4AH29 vs. peptide FAP-2286.

Dumauthioz N, Navarro L, Berdal M, Nagachinta S, Dewulf J, Van Eesbeek M, Plas S, Pinto J, Antunes ARP, Mantzilas D, D'Huyvetter M. Dumauthioz N, et al. Among authors: nagachinta s. EJNMMI Res. 2026 Feb 13;16(1):45. doi: 10.1186/s13550-026-01392-1. EJNMMI Res. 2026. PMID: 41688618 Free PMC article.

4

Radiolabelling of lipid-based nanocarriers with fluorine-18 for in vivo tracking by PET.

Nagachinta S, Becker G, Dammicco S, Serrano ME, Leroi N, Bahri MA, Plenevaux A, Lemaire C, Lopez R, Luxen A, de la Fuente M. Nagachinta S, et al. Colloids Surf B Biointerfaces. 2020 Apr;188:110793. doi: 10.1016/j.colsurfb.2020.110793. Epub 2020 Jan 13. Colloids Surf B Biointerfaces. 2020. PMID: 31982792

5

Automated and manual synthesis of [⁶⁸Ga]Ga-DOTA-4AH29 intended for PET-imaging of FAP-expression.

Berdal M, Nagachinta S, Langsberg X, Gaspariunaite V, Massa S, Pombo Antunes AR, Mantzilas D, D'Huyvetter M, Navarro L. Berdal M, et al. Among authors: nagachinta s. EJNMMI Radiopharm Chem. 2026 Jun 18;11(1):62. doi: 10.1186/s41181-026-00465-9. EJNMMI Radiopharm Chem. 2026. PMID: 42315731 Free PMC article.

6

Pharmacokinetics and dosimetry of radiolabeled FAP-targeting single-domain antibody 4AH29 in Göttingen minipigs.

Dumauthioz N, Navarro L, Berdal M, Nagachinta S, Eersels J, Gaspariunaite V, Antunes ARP, Dewulf J, Massa S, Jørgensen T, Kristensen LK, Starostka T, Mantzilas D, Lahoutte T, D'Huyvetter M. Dumauthioz N, et al. Among authors: nagachinta s. Nucl Med Biol. 2026 Jul-Aug;158-159:109654. doi: 10.1016/j.nucmedbio.2026.109654. Epub 2026 Jun 25. Nucl Med Biol. 2026. PMID: 42364406 Free article.

7

Efficient α and β^- radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model.

Ceuppens H, Pombo Antunes AR, Navarro L, Ertveldt T, Berdal M, Nagachinta S, De Ridder K, Lahoutte T, Keyaerts M, Devoogdt N, Goyvaerts C, D'Huyvetter M, Breckpot K. Ceuppens H, et al. Among authors: nagachinta s. Eur J Nucl Med Mol Imaging. 2025 Jan;52(2):444-457. doi: 10.1007/s00259-024-06914-4. Epub 2024 Sep 6. Eur J Nucl Med Mol Imaging. 2025. PMID: 39237746

8

Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics.

Nagachinta S, Bouzo BL, Vazquez-Rios AJ, Lopez R, Fuente M. Nagachinta S, et al. Pharmaceutics. 2020 Feb 22;12(2):189. doi: 10.3390/pharmaceutics12020189. Pharmaceutics. 2020. PMID: 32098309 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year